Tags : pressroom

PharmaShots Weekly Snapshot (November 24 – 29, 2018)

Novartis’ Gilenya (fingolimod) Receives EU’s Approval for Relapsing-Remitting Forms of Multiple Sclerosis (RRMS) Published: 29 Nov, 2018 | Tags: Novartis, Gilenya, (fingolimod), Receives, EU, Approval, Relapsing-Remitting, Forms, Multiple Sclerosis (RRMS), 10 to <18 yrs, PARADIGMS study, P-III NTU Singapore & TTSH Develops AI based Smart Medical Device for Early Detection of Congestive Heart Failure Published: […]Read More

NTU SingaporeTTSH Develops AI based Smart Medical Device for Early

Shots: The medical device resembles to a stethoscope and has shown results demonstrating 92% accuracy in identifying patients with Congestive Heart Failure compared to current methods i.e. X-ray, CT scans The non-invasive device with AI sensors placed on chest or back, enables early detection of excess fluid in lungs within 10 seconds, when attached to […]Read More